[See all essays on this Hot Topic] A few weeks ago, pharmaceutical giant Eli Lilly announced that their latest Phase II trial for a drug named solanezumab, which is designed to flush beta-amyloid protein out of the brain and thereby ameliorate the symptoms of...
Enric Bufill MD Ph D Hospital Universitari de Vic, c.Francesc Pla 1, 08500, Barcelona Spain. Alzheimer’s disease (AD), the most common cause of dementia, is a complex disease associated with advanced age whose causes are still not fully known. AD is very...
Caleb E. Finch Leonard Davis School of Gerontology and Dornsife College, University of Southern California, Los Angeles CA Environmental influences on Alzheimer’s disease (AD) are under appreciated. The 25-year search for AD genes has clearly shown that...
[See all posts on this Hot Topic] Robert D. Moir Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Disease; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA ...
